The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
Official Title: Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp (LEIDA)
Study ID: NCT00777127
Brief Summary: This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream or Solaraze® 3% gel on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hospital Feldkirch, Department for Dermatology and Venereology, Feldkirch, , Austria
Medical University Graz, University Clinic for Dermatology and Venereology, Graz, , Austria
Medical University Innsbruck, University Clinic for Dermatology and Venereology, Innsbruck, , Austria
Medical University Vienna, Department for General Dermatology, Vienna, , Austria
CHU St Jacques, Department for Dermatology, Besancon Cedex, , France
Hospital Sainte Marguerite, Department for Dermatology and Venereology, Pavilion 3, First Floor, Marseille, , France
CHU Nice - Hospital Archet 2, Department for Dermatology, Nice, , France
Hospital Saint-Louis, Derpartment for Dermatology, Paris, , France
Hospital Center Lyon South, Department for Dermatology and Immuno-Allergology, Pierre Benite, , France
Licca Clinical Research Institute, Augsburg, , Germany
Charite - Medicine University Berlin, Dermatoma Center, Clinic for Dermatology, Allergology and Venereology, Berlin, , Germany
Medical Practice Dominicus / Bockhorst, Duelmen, , Germany
Medical practice, Düsseldorf, , Germany
University Clinic Düsseldorf, Clinic for Dermatology, Düsseldorf, , Germany
Clinic and Medical Faculty of Johann Wolfgang Goethe-University, Center for Dermatology and Venereology, Frankfurt am Main, , Germany
SCiderm GmbH, Hamburg, , Germany
Medical Practice, Hannover, , Germany
University Clinic Schleswig-Holstein, Campus Kiel, Clinic for Dermatology, Venereology and Allergology, Kiel, , Germany
Medical Department of Otto-von-Guericke-University Magdeburg, University Clinic for Dermatology and Venereology, Magdeburg, , Germany
Department of Dermatology J. Gutenberg-University Mainz, Clinical Research Center, Mainz, , Germany
Science, Onco & Beauty GbR, Practice for Dermatology and Medical Cosmetics, Mönchengladbach, , Germany
University Clinic Münster, Clinic and Polyclinic for Skin Diseases, Münster, , Germany
Clinic University Regensburg, Clinic and Polyclinic for Dermatology, Regensburg, , Germany
Derma Center Vechta, Vechta, , Germany
Centrovital, Witten, , Germany
Medical practice for Dermatology and Venerology, Wuppertal, , Germany
Name: Harald Gollnick, MD, Prof.
Affiliation: Otto-von-Guericke-University of Magdeburg/Germany, Clinic for Dermatology and Venereology
Role: PRINCIPAL_INVESTIGATOR
Name: Ursula Petzold, PhD
Affiliation: MEDA Pharma GmbH & Co. KG, Bad Homburg/Germany
Role: STUDY_DIRECTOR